Clearance Summary
BioTraceIO Lite received FDA 510(k) clearance under submission number DEN230020, sponsored by Techsomed Medical Technologies , Ltd.. The device was reviewed via the Direct premarket notification pathway and assigned to the Radiology review panel. The statutory decision date of record is 2023-12-22.
- Submission: DEN230020
- Applicant / Sponsor: Techsomed Medical Technologies , Ltd.
- Clearance pathway: Direct
- Review panel: Radiology
- Device class: Class II
- Regulation citation: 21 CFR 892.2052
- Decision date: 2023-12-22
Classification & Regulation
This clearance is catalogued under FDA product code QZL and 21 CFR 892.2052, within the Radiology review panel as a Class II device.